LAMEDITECH's 'Handyray Series Laser Lancet' receives TFDA 카지노 바카라 device certification in Taiwan
- "Demonstrates product reliability and excellence through Taiwanese distribution contracts and 카지노 바카라 device certification" - "Potential for full-scale market entry in Taiwan’s blood market following TFDA certification"
[by Lee, Young Sung] LAMEDITECH, a healthcare and beauty device manufacturer specializing in laser technology, announced on May 7 that it has obtained 카지노 바카라 device certification (TFDA) from the Ministry of Health and Welfare (MoHW) in Taiwan for its laser lancing device HandyRay series.
The HandyRay series covered by this certification includes two models: the HandyRay-Lite, designed for personal use, and the HandyRay-Pro, intended for 카지노 바카라 institutions. The series has been recognized as an innovative product by the Public Procurement Service for its needle-free laser lancing technology, which offers advantages such as hygienic blood collection, reduced pain, and no risk of callus formation.
Notably, it took two years to obtain 카지노 바카라 device certification following the signing of a distribution agreement with its Taiwanese partner, ‘K2 International 카지노 바카라 Inc.’
Founded in 2006, K2 International 카지노 바카라 Inc. is a distributor serving over 100 카지노 바카라 institutions across Asia. As a company specializing in distribution channels for blood banks and related products, it is responsible for the sales of LAMEDITECH’s laser blood collection devices in Taiwan.
“K2 International 카지노 바카라 Inc. has already secured a distribution contract targeting Taiwanese blood banks,” a LAMEDITECH official stated. “With this certification, we will now begin full-scale sales in the Taiwanese blood market.”